iopromide has been researched along with von Hippel-Lindau Disease in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davenport, MS | 1 |
| Caoili, EM | 1 |
| Cohan, RH | 1 |
| Hoff, CN | 1 |
| Ellis, JH | 1 |
1 other study available for iopromide and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Pancreatic manifestations of von Hippel-Lindau disease-effect of imaging on clinical management.
Topics: Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; I | 2010 |